MedPath

Comparing Vitamin D Doses in children with Epilepsy on Valproate: 400 IU vs. 600 IU for Bone Health

Phase 2
Conditions
Health Condition 1: G409- Epilepsy, unspecified
Registration Number
CTRI/2024/07/069705
Lead Sponsor
Department of Pediatrics, Lok Nayak Hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Children aged 2–12 years newly diagnosed (or within 4 days of diagnosis) with epilepsy and prescribed or planned to be prescribed sodium valproate monotherapy.

Exclusion Criteria

Abnormal Vitamin D levels at the time of assessment

Clinical rickets

Presence of chronic renal or liver disease

Non ambulatory status or tube fed status

Vitamin D supplementaion in last 3 months

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath